908 research outputs found
Protecting Online Privacy in the Digital Age: \u3ci\u3e Carpenter v. United States \u3c/i\u3e and the Fourth Amendment’s Third-Party Doctrine
The goal of this paper is to examine the future of the third-party doctrine with the proliferation of technology and the online data we are surrounded with daily, specifically after the Supreme Court’s decision in Carpenter v. United States. It is imperative that individuals do not forfeit their Constitutional guarantees for the benefit of living in a technologically advanced society. This requires an understanding of the modern-day functional equivalents of “papers” and “effects.”
Looking to the future, this paper contemplates solutions on how to move forward in this technology era by scrutinizing the relevancy of the third-party doctrine due to the rise of technology and the enormous amount of information held by third parties. The third-party doctrine may have been good law, but that time has passed. It is time for the third-party doctrine to be abolished so the Fourth Amendment can join the twenty-first century
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis
Extracellular fibrinolysis, controlled by the membrane-bound fibrinolytic system, is involved in cartilage damage and rheumatoid arthritis (RA) synovitis. Estrogen status and metabolism seem to be impaired in RA, and synoviocytes show receptors for estrogens. Our aims in this study were to evaluate in healthy and RA synoviocytes the effects of Raloxifene (RAL), a selective estrogen receptor modulator (SERM), on: proliferation; the components of the fibrinolytic system; and chemoinvasion. The effects of RAL were studied in vitro on synoviocytes from four RA patients and four controls. Proliferation was evaluated as cell number increase, and synoviocytes were treated with 0.5 μM and 1 μM RAL with and without urokinase-plasminogen activator (u-PA) and anti-u-PA/anti-u-PA receptor (u-PAR) antibodies. Fibrinolytic system components (u-PA, u-PAR and plasminogen activator inhibitor (PAI)-1) were assayed by ELISA with cells treated with 0.5 μM and 1 μM RAL for 48 h. u-PA activity was evaluated by zymography and a direct fibrinolytic assay. U-PAR/cell and its saturation were studied by radioiodination of u-PA and a u-PA binding assay. Chemoinvasion was measured using the Boyden chamber invasion assay. u-PA induced proliferation of RA synoviocytes was blocked by RAL (p < 0.05) and antagonized by antibodies alone. The inhibitory effect of RAL was not additive with u-PA/u-PAR antagonism. RA synoviocytes treated with RAL showed, compared to basal, higher levels of PAI-1 (10.75 ± 0.26 versus 5.5 ± 0.1 μg/10(6 )cells, respectively; p < 0.01), lower levels of u-PA (1.04 ± 0.05 versus 3.1 ± 0.4 ng/10(6 )cells, respectively; p < 0.001), and lower levels of u-PAR (11.28 ± 0.22 versus 23.6 ± 0.1 ng/10(6 )cells, respectively; p < 0.001). RAL also significantly inhibited u-PA-induced migration. Similar effects were also shown, at least partially, in controls. RAL exerts anti-proliferative and anti-invasive effects on synoviocytes, mainly modulating u-PAR and, to a lesser extent, u-PA and PAI-1 levels, and inhibiting cell migration and proliferation
Tandem chemiluminescence-flow injection analysis for dimethoate determination
This work was supported by the Ministry of Education and Science of Spain (Project CTM2006-11991) and FEDER funds.Catalá Icardo, M.; López Paz, JL.; Choves Barón, C. (2010). Tandem chemiluminescence-flow injection analysis for dimethoate determination. Luminescence. 25:235-236. https://doi.org/10.1002/bio.1217S2352362
Analysis of time-profiles with in-beam PET monitoring in charged particle therapy
Background: Treatment verification with PET imaging in charged particle
therapy is conventionally done by comparing measurements of spatial
distributions with Monte Carlo (MC) predictions. However, decay curves can
provide additional independent information about the treatment and the
irradiated tissue. Most studies performed so far focus on long time intervals.
Here we investigate the reliability of MC predictions of space and time (decay
rate) profiles shortly after irradiation, and we show how the decay rates can
give an indication about the elements of which the phantom is made up.
Methods and Materials: Various phantoms were irradiated in clinical and
near-clinical conditions at the Cyclotron Centre of the Bronowice proton
therapy centre. PET data were acquired with a planar 16x16 cm PET system.
MC simulations of particle interactions and photon propagation in the phantoms
were performed using the FLUKA code. The analysis included a comparison between
experimental data and MC simulations of space and time profiles, as well as a
fitting procedure to obtain the various isotope contributions in the phantoms.
Results and conclusions: There was a good agreement between data and MC
predictions in 1-dimensional space and decay rate distributions. The fractions
of C, O and C that were obtained by fitting the decay
rates with multiple simple exponentials generally agreed well with the MC
expectations. We found a small excess of C in data compared to what was
predicted in MC, which was clear especially in the PE phantom.Comment: 9 pages, 5 figures, 1 table. Proceedings of the 20th International
Workshop on Radiation Imaging Detectors (iWorid2018), 24-28 June 2018,
Sundsvall, Swede
- …